These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 1495522)

  • 1. The course of seizures after treatment for cerebral cysticercosis.
    Vazquez V; Sotelo J
    N Engl J Med; 1992 Sep; 327(10):696-701. PubMed ID: 1495522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis.
    Garcia HH; Pretell EJ; Gilman RH; Martinez SM; Moulton LH; Del Brutto OH; Herrera G; Evans CA; Gonzalez AE;
    N Engl J Med; 2004 Jan; 350(3):249-58. PubMed ID: 14724304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug treatment of neurocysticercosis.
    Garg RK
    Natl Med J India; 1997; 10(4):173-7. PubMed ID: 9325640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors for seizure recurrence after withdrawal of antiepileptic drugs in patients with neurocysticercosis.
    Del Brutto OH
    Neurology; 1994 Sep; 44(9):1706-9. PubMed ID: 7936301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel.
    Del Brutto OH; Roos KL; Coffey CS; García HH
    Ann Intern Med; 2006 Jul; 145(1):43-51. PubMed ID: 16818928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Selective sensitivity of cysts to praziquantel and albendazole in a case of cerebral cysticercosis].
    Cohen L; Belec L; Sanson M; Pierrot-Deseilligny C; Signoret JL
    Rev Neurol (Paris); 1992; 148(1):58-61. PubMed ID: 1604116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of anticysticercal treatment on the prognosis of epilepsy in neurocysticercosis: a pilot trial.
    Medina MT; Genton P; Montoya MC; Córdova S; Dravet C; Sotelo J
    Epilepsia; 1993; 34(6):1024-7. PubMed ID: 8243351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the course of neurocysticercosis modified by treatment with antihelminthic agents?
    Carpio A; Santillán F; León P; Flores C; Hauser WA
    Arch Intern Med; 1995 Oct; 155(18):1982-8. PubMed ID: 7575052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of albendazole and praziquantel in the treatment of cerebral cysticercosis.
    Cruz M; Cruz I; Horton J
    Southeast Asian J Trop Med Public Health; 1991 Dec; 22 Suppl():279-83. PubMed ID: 1822906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cysticidal therapy: impact on seizure control in epilepsy associated with neurocysticercosis.
    Santos IC; Kobayashi E; Cardoso TM; Guerreiro CA; Cendes F
    Arq Neuropsiquiatr; 2000 Dec; 58(4):1014-20. PubMed ID: 11105066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocysticercosis in children.
    Puri V; Sharma DK; Kumar S; Choudhury V; Gupta RK; Khalil A
    Indian Pediatr; 1991 Nov; 28(11):1309-17. PubMed ID: 1808053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy of parenchymal brain cysticercosis with praziquantel.
    Sotelo J; Escobedo F; Rodriguez-Carbajal J; Torres B; Rubio-Donnadieu F
    N Engl J Med; 1984 Apr; 310(16):1001-7. PubMed ID: 6708975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiparasitic treatment of neurocysticercosis - The effect of cyst destruction in seizure evolution.
    Garcia HH; Del Brutto OH;
    Epilepsy Behav; 2017 Nov; 76():158-162. PubMed ID: 28606690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Albendazole versus praziquantel in the treatment of cerebral cysticercosis: clinical evaluation.
    Cruz M; Cruz I; Horton J
    Trans R Soc Trop Med Hyg; 1991; 85(2):244-7. PubMed ID: 1887483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albendazole therapy for neurocysticercosis.
    Escobedo F; Penagos P; Rodriguez J; Sotelo J
    Arch Intern Med; 1987 Apr; 147(4):738-41. PubMed ID: 3827462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine cysticercosis model: influence of the infection time and the time of treatment on the cysticidal efficacy of albendazole and praziquantel.
    Palomares-Alonso F; Palencia Hernández G; Rojas-Tomé IS; Jung-Cook H; Pinzón-Estrada E
    Exp Parasitol; 2015 Feb; 149():1-6. PubMed ID: 25500213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of praziquantel and albendazole in neurocysticercosis.
    Gupta R; Yadav NV
    J Assoc Physicians India; 1990 Apr; 38(4):313-4. PubMed ID: 2391343
    [No Abstract]   [Full Text] [Related]  

  • 18. Short course of albendazole therapy for neurocysticercosis.
    Sotelo J; Penagos P; Escobedo F; Del Brutto OH
    Arch Neurol; 1988 Oct; 45(10):1130-3. PubMed ID: 3178533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neurocysticercosis in children: clinical and radiological analysis and prognostic factors in 54 patients].
    del Brutto OH
    Rev Neurol; 1997 Nov; 25(147):1681-4. PubMed ID: 9484517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis.
    Sotelo J; del Brutto OH; Penagos P; Escobedo F; Torres B; Rodriguez-Carbajal J; Rubio-Donnadieu F
    J Neurol; 1990 Apr; 237(2):69-72. PubMed ID: 2192018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.